This update provides an overview of key regulatory developments in the past three months relevant to companies listed or planning to list on The Stock Exchange of Hong Kong Limited (HKEx) and to their advisers. In particular,...more
With ongoing regulatory developments affecting capital markets globally, many China-related businesses are considering pursuing their IPOs in Hong Kong. However, the regulatory regime for IPOs on the Stock Exchange of Hong...more
This update provides an overview of key regulatory developments in the past three months relevant to companies listed, or planning to list, on The Stock Exchange of Hong Kong Limited (HKEx), and their advisers. In particular,...more
Our second annual report on Hong Kong-listed biotech companies demonstrates the continued health of the sector. The report provides a comprehensive overview of the market in its current state, examining key data points for...more
This update provides an overview of key regulatory developments in the past three months relevant to companies listed, or planning to list, on The Stock Exchange of Hong Kong Limited (HKEx), and their advisers. In particular,...more
This update provides an overview of key regulatory developments from Q4 2021 relevant to companies listed or planning to list on The Stock Exchange of Hong Kong Limited (HKEx) and to their advisers. In particular, it covers...more
Takeaways -
Greater China companies operating in any industry can now obtain secondary listings in Hong Kong, provided they meet market capitalization minimums.
Recent Listing Rules amendments also allow some companies...more
HKEx Finalizes New Rules on Listings for Overseas Issuers -
Following a consultation process conducted earlier in 2021, the Stock Exchange of Hong Kong Limited (HKEx) has announced amended listing rules for overseas...more
This update provides an overview of key regulatory developments in the past three months relevant to companies listed or planning to list on The Stock Exchange of Hong Kong Limited (HKEx), and their advisers. In particular,...more
10/8/2021
/ Capital Markets ,
Corporate Governance ,
HKEx ,
Hong Kong ,
Hong Kong Securities and Futures Commission (HKSFC) ,
Hong Kong Stock Exchange ,
Initial Public Offering (IPO) ,
Listing Rules ,
Private Investment in Public Equity (PIPEs) ,
Publicly-Traded Companies ,
Special Purpose Acquisition Companies (SPACs)
With ongoing regulatory developments affecting capital markets globally, many China-related businesses are considering pursuing their IPOs in Hong Kong. However, the regulatory regime for IPOs on the Stock Exchange of Hong...more
查看中文 - This update provides an overview of key regulatory developments in the past three months relevant to companies listed, or planning to list, on The Stock Exchange of Hong Kong Limited (HKEx), and their advisers. In...more
This update provides an overview of key regulatory developments in the past three months relevant to companies listed, or planning to list, on The Stock Exchange of Hong Kong Limited (HKEX), and their advisers. In particular,...more
4/15/2021
/ Annual Reports ,
Corporate Governance ,
Disclosure Requirements ,
HKEx ,
Hong Kong ,
Hong Kong Securities and Futures Commission (HKSFC) ,
Hong Kong Stock Exchange ,
Listing Rules ,
New Guidance ,
Publicly-Traded Companies ,
Takeover Code
On February 23, 2018, the Stock Exchange of Hong Kong Limited (HKEX) published its consultation conclusions regarding a new chapter of its listing rules to facilitate the listings of pre-revenue biotech companies in Hong...more
Despite the impact of COVID-19 and other recent developments in Hong Kong, the city’s role as a center for China-based companies to raise capital became even more important in 2020. The momentum of several trends that began...more
1/29/2021
/ Biotechnology ,
Capital Markets ,
Capital Raising ,
China ,
Foreign Relations ,
HKEx ,
Hong Kong ,
Hong Kong Stock Exchange ,
Initial Public Offering (IPO) ,
PCAOB ,
Publicly-Traded Companies ,
Securities and Exchange Commission (SEC)
查看中文 -
This update provides an overview of key regulatory developments in the past three months relevant to companies listed, or planning to list, on The Stock Exchange of Hong Kong Limited (HKEx), and their advisers. In...more
Open banking is an important driver of the fintech revolution. Regulators have recognised open banking as a means of introducing competition and innovation in the banking sector. Likewise, fintechs are seizing the...more
10/28/2020
/ APIs ,
Banking Sector ,
Banks ,
Basel Committee on Banking Supervision (BCBS) ,
Consent ,
Cybersecurity ,
Data Protection ,
EU ,
European Economic Area (EEA) ,
Financial Institutions ,
FinTech ,
General Data Protection Regulation (GDPR) ,
Monopolization ,
Open Banking ,
Popular ,
PSD2 ,
Regulatory Standards ,
Risk Management ,
Third Party Purchaser (TPP)
The Hong Kong Stock Exchange continues to pursue and implement a number of rule changes aimed at making the listing process more efficient while strengthening and broadening its role overseeing listed companies and the tools...more
This update provides an overview of key regulatory developments in the past three months relevant to companies listed, or planning to list, on The Stock Exchange of Hong Kong Limited (HKEx), and their advisers. In particular,...more
7/14/2020
/ Acquisitions ,
Amended Rules ,
Biotechnology ,
Board of Directors ,
Censures ,
Corporate Executives ,
Enforcement Actions ,
False Statements ,
Hang Seng China Enterprises Index (HSCEI) ,
Hang Seng Index (HSI) ,
HKEx ,
Hong Kong ,
Hong Kong Securities and Futures Commission (HKSFC) ,
Hong Kong Stock Exchange ,
Internal Controls ,
Listing Applications ,
Listing Rules ,
Medical Devices ,
Medical Research ,
Mergers ,
Misappropriation ,
Misleading Statements ,
Pharmaceutical Industry ,
Publicly-Traded Companies ,
Sanctions ,
Secondary Listings ,
SFC ,
Shareholders ,
Takeovers ,
Weighted Voting Rights (WVR)
This update provides an overview of key regulatory developments in the past three months relevant to companies listed, or planning to list, on The Stock Exchange of Hong Kong Limited (HKEx) and their advisers. In particular,...more
4/3/2020
/ Annual Reports ,
Coronavirus/COVID-19 ,
Enforcement Actions ,
Environmental Social & Governance (ESG) ,
HKEx ,
Hong Kong ,
Hong Kong Securities and Futures Commission (HKSFC) ,
Listing Rules ,
Publicly-Traded Companies ,
Regulatory Requirements ,
relief ,
Relief Measures ,
Shareholder Meetings ,
Virtual Meetings ,
Weighted Voting Rights (WVR)
Despite political and economic uncertainties, markets and deal activity were resilient in 2019, and strong fundamentals remain in place heading into 2020. Companies continue to face a challenging litigation and enforcement...more
1/30/2020
/ Acquisitions ,
Administrative Procedure Act ,
Anti-Discrimination Policies ,
Anti-Harassment Policies ,
Anti-Kickback Statute ,
Antitrust Investigations ,
Appeals ,
Arbitration Awards ,
Attorney General ,
Backstop Agreements ,
BEPS ,
BitLicense ,
Blockchain ,
Board of Directors ,
Bonds ,
Capital Markets ,
CFIUS ,
CFTC ,
Chapter 11 ,
Claim Preclusion ,
Class Action ,
Commercial Bankruptcy ,
Common Stock ,
Congressional Investigations & Hearings ,
Congressional Subpoenas ,
Consumer Financial Protection Bureau (CFPB) ,
Cooperation Agreement ,
Copyright ,
Corporate Governance ,
Corporate Restructuring ,
Corporate Social Responsibility ,
Corporate Taxes ,
Corwin Doctrine ,
Covenant Lite Deals ,
Creditors ,
Cross-Border Transactions ,
DACA ,
DE Supreme Court ,
Debt Financing ,
Debtors ,
Department of Justice (DOJ) ,
Dischargeable Debts ,
Disgorgement ,
Disparate Impact ,
Dodd-Frank ,
Down Rounds ,
Drug Pricing ,
EBITDA ,
Employee Retirement Income Security Act (ERISA) ,
Employer Liability Issues ,
Employment Discrimination ,
Enforcement Actions ,
Enforcement of Foreign Judgments ,
Enterprise Act 2002 ,
Environmental Social & Governance (ESG) ,
EU ,
Fair Housing Act (FHA) ,
Federal Trade Commission (FTC) ,
FinTech ,
FIRRMA ,
Foreign Acquisitions ,
Foreign Investment ,
Foreign Issuers ,
FRCP 23 ,
General Data Protection Regulation (GDPR) ,
General Elections ,
GILTI tax ,
High-Yield Markets ,
Hong Kong ,
Hong Kong Stock Exchange ,
Individual Accountability ,
Initial Public Offering (IPO) ,
Intellectual Property Litigation ,
Intercreditor Agreements ,
International Arbitration ,
International Litigation ,
IRS ,
Issue Preclusion ,
Japan ,
Joint Venture ,
Legislative Agendas ,
Life Sciences ,
Listing Rules ,
Litigation Strategies ,
Make-Whole Premium ,
Mergers ,
MFW ,
Multinationals ,
National Security ,
PCAOB ,
Pharmaceutical Industry ,
Political Parties ,
Preferred Shares ,
Private Offerings ,
Privately Held Corporations ,
Proxy Advisory Firms ,
Publicly-Traded Companies ,
Refinancing ,
Regulatory Agenda ,
Reporting Requirements ,
SCOTUS ,
Securities and Exchange Commission (SEC) ,
Securities Litigation ,
Separation of Powers ,
Shareholder Activism ,
Shareholder Proposals ,
Shareholders ,
Split of Authority ,
State Labor Laws ,
Stock Drop Litigation ,
Tax Cuts and Jobs Act ,
Tax Litigation ,
Technology Sector ,
Third-Party Release Agrements ,
Transparency ,
UK ,
UK Brexit ,
Valuation ,
White Collar Crimes
Leading Chinese e-commerce company Alibaba, which has a primary listing on the New York Stock Exchange, made its long-awaited Hong Kong Stock Exchange (HKEx) debut in November 2019. This marked the first secondary listing in...more
1/23/2020
/ China ,
Emerging Technology Companies ,
Foreign Issuers ,
Hong Kong ,
Hong Kong Stock Exchange ,
Innovative Technology ,
Listing Rules ,
New Rules ,
Popular ,
Publicly-Traded Companies ,
Secondary Listings ,
Securities ,
Shanghai Stock Exchange ,
Shenzhen Stock Exchange (SZSE) ,
Stock Connect ,
Weighted Voting Rights (WVR)
This update provides an overview of key regulatory developments in the past three months relevant to companies listed, or planning to list, on The Stock Exchange of Hong Kong Limited (HKEx), and their advisers. In particular,...more
1/8/2020
/ Acquisitions ,
Annual Reports ,
Beneficial Owner ,
Board of Directors ,
Breach of Duty ,
Censures ,
Compensation ,
Complex Corporate Transactions ,
Conflicts of Interest ,
Controlling Person ,
Criminal Convictions ,
Cross-Border Transactions ,
Debt Securities ,
Enforcement Actions ,
Environmental Social & Governance (ESG) ,
Failure to Cooperate ,
Filing Deadlines ,
Foreign Acquisitions ,
Foreign Offerings ,
HKEx ,
Hong Kong ,
Hong Kong Securities and Futures Commission (HKSFC) ,
Hong Kong Securities Clearing Company Limited (HKSCC) ,
Hong Kong Stock Exchange ,
Insider Trading ,
Investment Adviser ,
Listing Rules ,
Mandatory Disclosure Rules ,
Materiality ,
Publicly-Traded Companies ,
Regulatory Agenda ,
Reporting Requirements ,
Secondary Listings ,
Shareholder Approval ,
Trial Court Orders
This update provides an overview of recent developments that will affect preparation of annual results and annual reports for companies listed on The Stock Exchange of Hong Kong Limited (HKEX).
In particular, it covers...more
1/6/2020
/ Annual Reports ,
Biotechnology ,
Capital Requirements ,
Committee Meetings ,
Corporate Governance ,
Disclosure Requirements ,
Dual Class Share Structures ,
EBITDA ,
Enforcement Actions ,
Environmental Social & Governance (ESG) ,
Financial Statements ,
Foreign Corporations ,
Foreign Issuers ,
HKEx ,
Hong Kong ,
Hong Kong Securities and Futures Commission (HKSFC) ,
Hong Kong Stock Exchange ,
Investment Funds ,
Listing Rules ,
Materiality ,
Non-GAAP Financial Measures ,
Publicly-Traded Companies ,
Secondary Listings ,
Shareholder Meetings ,
Trade Suspensions ,
Voting Rights
This update provides an overview of key regulatory developments in the past three months relevant to companies listed, or planning to list, on The Stock Exchange of Hong Kong Limited (HKEx), and their advisers. In particular,...more
10/8/2019
/ Acquisitions ,
Censures ,
Consultation Periods ,
Corporate Issuers ,
Disclosure Requirements ,
Enforcement Actions ,
Fines ,
Foreign Issuers ,
HKEx ,
Hong Kong ,
Hong Kong Securities and Futures Commission (HKSFC) ,
Hong Kong Stock Exchange ,
Initial Public Offering (IPO) ,
Listing Rules ,
Public Consultations ,
Security Token Offering (STOs) ,
Stock Connect ,
Takeovers
On 26 July 2019, The Stock Exchange of Hong Kong Limited (HKEx) published conclusions to its consultation paper regarding backdoor listings, continuing listing criteria and other related Listing Rule amendments. The...more
8/2/2019
/ Amended Rules ,
Bright-Line Rule ,
Hong Kong ,
Hong Kong Stock Exchange ,
Listing Rules ,
Listing Standards ,
Publicly-Traded Companies ,
Reverse Takeovers ,
Securities Regulation ,
Securities Transactions ,
Shell Corporations